IBEC spin-off Nanobots Therapeutics has been selected in the AECC’s 2024 call for IMPACTO grants. This is an initiative of the Spanish Association Against Cancer (AECC) aimed at technology-based micro-enterprises and SMEs to accelerate the arrival of new treatments in the clinic. The grants were awarded in Barcelona today.
Today, the BIST Forum, an event that brings together the BIST scientific community, focused this year on the joint initiative of the seven CERCA centres to promote precision medicine in healthy ageing. During the event, the new BIST Ignite projects to promote multidisciplinary research were announced, with IBEC involved in four of the five selected projects. In addition, one of the projects in which IBEC is involved won a BIST Ignite Award.
Today, 19 February, IBEC organised the roundtable ‘Personalised medicine in action: from the lab to society’, an event that formed part of the Barcelona Health Innovation Week, promoted by Biocat. The session provided an insight into the keys to success in translating personalised medicine, connecting with actors in the innovation ecosystem and taking part in the conversation about the future of our health.
The Institute of Bioengineering of Catalunya (IBEC) reaffirms its commitment to scientific education by renewing for the fifth consecutive time its accreditation as a Unit of Scientific Culture and Innovation … Read more
On the occasion of World Cancer Day, celebrated on 4 February, more than 50 nanomedicine experts gathered today at the ‘Nano World Cancer Day’ event, held at the Vall d’Hebron … Read more
The President of the Catalan Government, Salvador Illa, and the Catalan Minister for Research and Universities, Núria Montserrat, inaugurated this unique infrastructure at the Barcelona Science Park today. The microscope, funded by IBEC and FEDER*, opens the door to the reconstruction of biomolecules and viruses in three dimensions, among other applications.
IBEC senior researcher Pere Roca-Cusachs has been awarded an ERC Proof of Concept Grant. This is a prestigious grant awarded by the European Research Council to explore the commercial and societal potential of research projects carried out at European institutions. Roca-Cusachs’ project, INTROPY, focuses on the inhibition of mechanotransduction as a potential therapy against cancer or fibrosis.
IBEC researcher Eduard Torrents has been awarded the ICREA Academia distinction by the Catalan Institute for Research and Advanced Studies (ICREA). The head of IBEC’s Bacterial Infections: Antimicrobial Therapies group received the award in the Life and Health Sciences category.
IBEC is one of four Catalan research centres collaborating with the Centre de Cultura Contemporània de Barcelona (CCCB) on the ‘Radical Science’ project. This cultural project, which will be launched on 20 January 2025, aims to explore how scientific research is changing the world today. Renowned researchers and artists invite us to reflect on scientific advances in biotechnology, quantum physics and the exploration of the universe.
This spin-off from the Institute for Bioengineering of Catalonia has developed a non-invasive technology that analyses the metabolism of human embryos to select the most suitable ones for implantation. This innovation promises to significantly reduce the time and number of treatment cycles required for in vitro fertilisation. The success of LUMIRIS’ technology has led to a new round of investment of €1.5 million, bringing the total to €6 million since the company was founded in 2023.